Navigating Staging and Treatment of Non-Small Cell Lung Cancer

This chapter explores the complexities of classifying non-small cell lung cancer at stage III, highlighting essential diagnostic evaluations and the significance of ruling out metastases. It also covers treatment advancements, particularly the impact of the PACIFIC trial and Dervalumab on managing unresectable stage III lung cancer post-chemoradiation.